{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:43:15Z","timestamp":1789432995113,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T00:00:00Z","timestamp":1391817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00296-014-2953-y","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T12:28:56Z","timestamp":1391776136000},"page":"1047-1052","source":"Crossref","is-referenced-by-count":47,"title":["Oxytocin nasal spray in fibromyalgic patients"],"prefix":"10.1007","volume":"34","author":[{"given":"S.","family":"Mameli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Pisanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Minerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Trincas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Agabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,8]]},"reference":[{"key":"2953_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4065\/mcp.2010.0738","volume":"86","author":"LM Arnold","year":"2011","unstructured":"Arnold LM, Clauw DJ, McCarberg BH (2011) Fibro collaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 86:457\u2013464","journal-title":"Mayo Clin Proc"},{"key":"2953_CR2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.comppsych.2012.03.008","volume":"53","author":"G Consoli","year":"2012","unstructured":"Consoli G, Marazziti D, Ciapparelli A, Bazzichi L, Massimetti G, Giacomelli C et al (2012) The impact of mood, anxiety, and sleep disorders on fibromyalgia. Compr Psychiatry 53:962\u2013967","journal-title":"Compr Psychiatry"},{"key":"2953_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.berh.2011.01.015","volume":"25","author":"PJ Mease","year":"2011","unstructured":"Mease PJ, Dundon K, Sarzi-Puttini P (2011) Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol 25:285\u2013297","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2953_CR4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1745017901309010120","volume":"9","author":"M Carta","year":"2013","unstructured":"Carta M, Ruggiero V, Sancassiani F, Cutrano F, Manca A, Peri M et al (2013) The use of antidepressants in the long-term treatment should not improve the impact of fibromyalgia on quality of life. Clin Pract Epidemiol Ment Health 9:120\u2013124","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"2953_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1176\/appi.neuropsych.13030061","volume":"25","author":"FL Stevens","year":"2013","unstructured":"Stevens FL, Weisman O, Feldman R, Hurley RA, Taber KH (2013) Oxytocin and behavior: evidence for effects in the brain. J Neuropsychiatry Clin Neurosci 25:96\u2013102","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2953_CR6","doi-asserted-by":"crossref","unstructured":"Rash JA, Aguirre-Camacho A, Campbell TS (2013) Oxytocin and pain: a systematic review and synthesis of findings. Clin J Pain [Epub ahead of print]","DOI":"10.1097\/AJP.0b013e31829f57df"},{"key":"2953_CR7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.neubiorev.2010.10.014","volume":"35","author":"MR Melis","year":"2011","unstructured":"Melis MR, Argiolas A (2011) Central control of penile erection: a re-visitation of the role of oxytocin and its interaction with dopamine and glutamic acid in male rats. Neurosci Biobehav Rev 35:939\u2013955","journal-title":"Neurosci Biobehav Rev"},{"key":"2953_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.regpep.2011.04.007","volume":"169","author":"J Yang","year":"2011","unstructured":"Yang J, Li P, Liang JY, Pan YJ, Yan XQ, Yan FL, Hao F et al (2011) Oxytocin in the periaqueductal grey regulates nociception in the rat. Regul Pept 169:39\u201342","journal-title":"Regul Pept"},{"key":"2953_CR9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2005.03.020","volume":"1045","author":"M Cond\u00e9s-Lara","year":"2005","unstructured":"Cond\u00e9s-Lara M, Maie IA, Dickenson AH (2005) Oxytocin actions on afferent evoked spinal cord neuronal activities in neuropathic but not in normal rats. Brain Res 1045:124\u2013133","journal-title":"Brain Res"},{"key":"2953_CR10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00007632-199404150-00001","volume":"19","author":"J Yang","year":"1994","unstructured":"Yang J (1994) Intrathecal administration of oxytocin induces analgesia in low back pain involving the endogenous opiate peptide system. Spine 19:867\u2013871","journal-title":"Spine"},{"key":"2953_CR11","first-page":"427","volume":"50","author":"I Madrazo","year":"1987","unstructured":"Madrazo I, Franco-Bourland RE, Le\u00f3n-Meza VM, Mena I (1987) Intraventricular somatostatin-14, arginine vasopressin, and oxytocin: analgesic effect in a patient with intractable cancer pain. Appl Neurophysiol 50:427\u2013431","journal-title":"Appl Neurophysiol"},{"key":"2953_CR12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.psyneuen.2012.11.019","volume":"38","author":"AJ Guastella","year":"2013","unstructured":"Guastella AJ, Hickie IB, McGuinness MM, Otis M, Woods EA, Hannah M et al (2013) Recommendations for the standardization of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology 38:612\u2013625","journal-title":"Psychoneuroendocrinology"},{"key":"2953_CR13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnins.2012.00174","volume":"6","author":"MH Ijzendoorn van","year":"2012","unstructured":"van Ijzendoorn MH, Bhandari R, van der Veen R, Grewen KM, Bakermans-Kranenburg MJ (2012) Elevated salivary levels of oxytocin persist more than 7\u00a0h after intranasal administration. Front Neurosci 6:174","journal-title":"Front Neurosci"},{"key":"2953_CR14","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S0140-6736(02)08601-4","volume":"359","author":"D Lawrance","year":"2002","unstructured":"Lawrance D (2002) Intranasal delivery could be used to administer drugs directly to the brain. Lancet 359:1674","journal-title":"Lancet"},{"key":"2953_CR15","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1176\/appi.neuropsych.23.2.E5","volume":"23","author":"G Scantamburlo","year":"2011","unstructured":"Scantamburlo G, Ansseau M, Geenen V, Legro JJ (2011) Intranasal oxytocin as an adjunct to escitalopram in major depression. J Neuropsychiatry Clin Neurosci 23:E5","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2953_CR16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.psyneuen.2009.01.005","volume":"34","author":"AJ Guastella","year":"2009","unstructured":"Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS (2009) A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34:917\u2013923","journal-title":"Psychoneuroendocrinology"},{"key":"2953_CR17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/scan\/nsq085","volume":"6","author":"J Bartz","year":"2011","unstructured":"Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A et al (2011) Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc Cogn Affect Neurosci 6:556\u2013563","journal-title":"Soc Cogn Affect Neurosci"},{"key":"2953_CR18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.psyneuen.2010.04.011","volume":"35","author":"A Perry","year":"2010","unstructured":"Perry A, Bentin S, Shalev I, Israel S, Uzefovsky F, Bar-On D et al (2010) Intranasal oxytocin modulates EEG mu\/alpha and beta rhythms during perception of biological motion. Psychoneuroendocrinology 35:1446\u20131453","journal-title":"Psychoneuroendocrinology"},{"key":"2953_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s003930070045","volume":"59","author":"UM Anderberg","year":"2000","unstructured":"Anderberg UM, Uvn\u00e4s-Moberg K (2000) Plasma oxytocin levels in female fibromyalgia syndrome patients. Z Rheumatol 59:373\u2013379","journal-title":"Z Rheumatol"},{"key":"2953_CR20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of rheumatology. Criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160\u2013172","journal-title":"Arthritis Rheum"},{"key":"2953_CR21","volume-title":"Manual for the state-trait anxiety inventory","author":"CD Spielberg","year":"1983","unstructured":"Spielberg CD (1983) Manual for the state-trait anxiety inventory. Consulting Psychologists Press, STAI (Form Y) Palo Alto, CA"},{"key":"2953_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","volume":"12","author":"WW Zung","year":"1965","unstructured":"Zung WW (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63\u201370","journal-title":"Arch Gen Psychiatry"},{"key":"2953_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220\u2013233","journal-title":"Med Care"},{"key":"2953_CR24","volume-title":"Pain measurement and assessment","author":"EC Huskisson","year":"1983","unstructured":"Huskisson EC (1983) Visual analog scale. In: Melzack R (ed) Pain measurement and assessment. Raven, New York, NY"},{"key":"2953_CR25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2010.04.039","volume":"68","author":"D Feifel","year":"2010","unstructured":"Feifel D, MacDonald K, Nguyen A, Cobb P, Warlan H, Galangue B et al (2010) Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry 68:678\u2013680","journal-title":"Biol Psychiatry"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-2953-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-2953-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-2953-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:51Z","timestamp":1559028111000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-2953-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2953"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-2953-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,8]]}}}